According to Fortune Business Insights: The global refurbished medical equipment market was valued at USD 14.28 billion in 2025 and is projected to climb from USD 15.73 billion in 2026 to USD 35.74 billion by 2034, reflecting a compound annual growth rate (CAGR) of 10.8% over the forecast period. North America led the global landscape with a 40.97% share in 2025.
Refurbished medical equipment refers to devices that undergo thorough cleaning, repair, testing, and certification before being resold — typically with a warranty. This allows healthcare facilities to access reliable, high-quality equipment at significantly reduced costs, often saving 30% to 70% compared to purchasing new devices.
Get a Sample Research PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/114797
Cost Savings for Healthcare Facilities remain the primary growth engine. New medical equipment carries high upfront costs, and when maintenance expenses are factored in, the financial burden on hospitals and clinics becomes substantial. Refurbished equipment addresses this challenge by lowering capital expenditure while still providing tested and warranted performance. Smaller hospitals and diagnostic centers, in particular, gain access to advanced machinery that would otherwise be beyond their budget.
Rising Demand for Diagnostics and Screening is further accelerating market expansion. Growing patient volumes and the push for broader screening programs are creating sustained demand for imaging and monitoring equipment, much of which can be sourced cost-effectively through refurbishment.
OEM Participation as an Emerging Trend is reshaping the market. Original equipment manufacturers such as GE HealthCare, Siemens Healthineers, and Philips are now directly offering refurbished systems, lending credibility and quality assurance to the segment. Hospitals increasingly prefer OEM-refurbished units due to standardized testing, defined service support, and assured spare parts availability.
Despite positive momentum, the market faces notable headwinds. A persistent stigma around quality and reliability of refurbished equipment causes hesitation among some hospital procurement teams, particularly when service history documentation is incomplete or parts availability is uncertain.
After-sales service consistency presents another challenge. Older or varied equipment models can complicate maintenance planning, and limited local service coverage in certain regions can result in extended downtime — a critical concern for diagnostic and life-support equipment.
By Product Type, medical imaging equipment holds the largest share. The high cost of new imaging systems — CT scanners, MRI machines, and X-ray units — makes refurbishment economically attractive. Surgical and operating room equipment is the fastest-growing sub-segment, projected to expand at a CAGR of 11.6%.
By Application, diagnostic and screening led the market in 2025, driven by rising procedure volumes and budget-conscious procurement strategies. Surgical and interventional procedures represent the next fastest-growing application segment at 11.3% CAGR.
By End-User, hospitals dominate with an estimated 65.0% share in 2026. Their diverse departmental needs — from imaging to anesthesia and monitoring — generate consistent, broad-based demand. Diagnostic imaging centers follow, growing at 11.1% CAGR.
North America leads globally, valued at USD 5.85 billion in 2025 and driven by a strong emphasis on cost reduction and large procurement volumes. The U.S. alone accounts for an estimated 35% of global revenues.
Europe is the second-largest region, projected to grow at 10.3% CAGR, reaching USD 4.24 billion in 2026. Germany (USD 0.98B) and the U.K. (USD 0.71B) are the primary contributors.
Asia Pacific stands third, estimated at USD 3.52 billion in 2026. China (USD 1.18B) and India (USD 0.79B) are the key markets, buoyed by expanding hospital infrastructure and a strong focus on cost optimization.